Policy & Advocacy

ASGCT Holds First Joint Meeting With Brazilian Association

ASGCT Staff - December 03, 2020

Speakers addressed the scientific and infrastructural requirements for successful translation into clinical research for oncology, hemophilia, and sickle cell disease.

ASGCT held its first ever collaborative event with the Brazilian Association of Cellular and Gene Therapy (ABTCel-Gen) virtually Dec. 2. Academic researchers from Brazil and the U.S. shared their experiences in establishing clinical trials for gene therapies to assist in advancing further development within Brazil. The ASGCT Global Outreach Committee co-hosted this program as part of its objective to encourage clinical development in middle-income countries that have burgeoning regulatory frameworks and medical systems that can support gene therapy. By facilitating the development and approval of more therapies globally, such events contribute to the Society’s strategic goal to foster equitable access to gene and cell therapies in low- and middle-income countries.

Speakers addressed the scientific and infrastructural requirements for successful translation into clinical research for oncology, hemophilia, and sickle cell disease. In addition, ASGCT Board Member Maritza McIntyre, Ph.D., provided recommendations on information to include in an IND application and ways to overcome common regulatory challenges in gene therapy trials. A recording of the program is available below. The Society will continue to partner with ABTCel-Gen when ASGCT members speak on gene editing at ABTCel-Gen’s virtual annual meeting in April.

Related Articles

Policy & Advocacy

FDA Cell & Gene Therapy Roundtable: Putting Every Patient Within Reach of Innovation

Terry Flotte, MD, and Paula Cannon, PhD - June 11, 2025
Annual Meeting 2025

ASGCT Builds Bridges: Advancing Access Through Patient-Centered and Global Initiatives

Caitlin McCombs, MBA; Ali Kujawski, MPH; and Lexi Starosta - June 10, 2025
Policy & Advocacy

Final Month to Apply for the Congressional Policy Fellowship

Adriana Bankston, PhD - January 24, 2025
Policy & Advocacy

Join Leading Experts for an FDA-ASGCT Workshop on AAV Gene Therapy Immunogenicity

Andrew Liermann - January 13, 2025